Pfe Stock Forecast, Price News Pfizer

Pfizer Inc. on Thursday announced positive results from a late-stage trial of a meningococcal vaccine candidate PFE called MenABCWY in adolescents and said it will submit an application for approval to the U.S.

PFE’s full-year Zacks Consensus Estimates are calling for earnings of $6.54 per share and revenue of $101.13 http://dotbig.com/markets/stocks/PFE/ billion. These results would represent year-over-year changes of +47.96% and +24.1%, respectively.

Free Report) closed at $46.15, marking a -0.09% move from the previous day. Elsewhere, the Dow gained 0.1%, while the tech-heavy Nasdaq lost 0.05%. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with https://dotbig.com/ the worst average Zacks Rank would place in the bottom 1%. An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. Plus, PFE info will be updated daily in your Zacks.com Portfolio Tracker – also free.

Pfizer

Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. 18 Wall Street analysts have issued 12-month target prices Forex for Pfizer’s shares. Their PFE share price forecasts range from $44.00 to $76.00. On average, they anticipate the company’s stock price to reach $57.00 in the next year. This suggests a possible upside of 25.4% from the stock’s current price.

  • This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock’s expected earnings growth rate.
  • Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat’s FREE daily newsletter.
  • In the past three months, Pfizer insiders have not sold or bought any company stock.
  • The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank.
  • PFE’s full-year Zacks Consensus Estimates are calling for earnings of $6.54 per share and revenue of $101.13 billion.

View analysts price targets for PFE or view top-rated stocks among Wall Street analysts. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, https://dotbig.com/ government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc.

Key Data

The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average dotbig website Zacks Rank. The scores are based on the trading styles of Value, Growth, and Momentum.

PFE stock

Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. As an investor, dotbig forex you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the https://www.dukascopy.com/swiss/english/forex/trading/ monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month.

Pfizer will be looking to display strength as it nears its next earnings release. On that day, Pfizer is projected to report earnings of $1.66 per share, which would represent year-over-year growth of 23.88%. Meanwhile, our latest consensus estimate is calling for revenue of $22.46 billion, down 6.8% from the prior-year quarter. The technique has proven to be very useful for finding positive surprises.

Pfe Company Calendar

This indicates that Pfizer will be able to sustain or increase its dividend. Pfizer has a short interest ratio (“days to cover”) of 3.3, which is generally considered an acceptable ratio of short interest to trading volume. A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. Our experts picked 7 Zacks Rank #1 Strong Buy stocks dotbig with the best chance to skyrocket within the next days. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. There may be delays, omissions, or inaccuracies in the Information.

Analyst Ratings

1.11% of the outstanding shares of Pfizer have been sold short. According to analysts’ consensus price target of $57.00, Pfizer has a forecasted upside of 27.3% from its current price of $44.79. Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with “60 Minutes” that aired on Sunday. The Large Cap Pharmaceuticals industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 94, which puts it in the top 38% of all 250+ industries.

Intraday data delayed at least 15 minutes or per exchange requirements. View our full suite of financial calendars and market data tables, all for free. Real-time analyst ratings, insider transactions, earnings data, and more.

MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. 358 employees have rated Pfizer Chief Executive Officer Albert Bourla on Glassdoor.com. Albert Bourla has an approval rating of 92% among the company’s employees. This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Deixe uma resposta

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *